PIQ
PROTEOMICS INTERNATIONAL LABORATORIES LTD
$0.1400
▲ +7.69%
Market cap
$23M
Turnover
$69,321
Last price
$0.1400
Day change
+7.69%
Announcements
11
Range, past year
Open 0.380 · Low 0.096 · Now 0.140 · High 0.860
Open PIQ in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
PIQ momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
24/100
Wyckoff phase
Accumulation9d
Trend stage
Neutral
1 Day
+7.7%
1 Week
+16.7%
1 Month
+0.0%
1 Year
-61.6%
RSI
56
Avg daily range
7.0%
PROTEOMICS INTERNATIONAL LABORATORIES LTD scores 24 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 9 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads low.
What stands out
- RSI in healthy zone (56)
Points to watch
- 60d drawdown -37.8%
- High volatility (ATR 7.0%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
PIQ announcements
Recent price-sensitive releases.
- 2026-10-13 PromarkerEndo Validation and Refinement Complete Progress Report
- 2026-09-14 PromarkerD and PromarkerEso Commercial Rollout Update Progress Report
- 2026-08-31 Appendix 4E and Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-08-13 Australian patent for PromarkerEndo Progress Report
- 2026-07-27 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-22 Proteomics signs national distribution deal with Healius
- 2026-07-08 US patent secured for PromarkerEndo
More Health Care stocks
Most traded in the same sector.